| Dr Janine Grace Lastimosa Tennant, PHARMD | |
|
4601 Dale Rd, Modesto, CA 95356-9718 | |
| (209) 735-5000 | |
| Not Available |
| Full Name | Dr Janine Grace Lastimosa Tennant |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4601 Dale Rd, Modesto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598311227 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 71059 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Janine Grace Lastimosa Tennant, PHARMD 12122 Kirkwood St, Herald, CA 95638-9764 Ph: () - | Dr Janine Grace Lastimosa Tennant, PHARMD 4601 Dale Rd, Modesto, CA 95356-9718 Ph: (209) 735-5000 |
News Archive
The health of people who never marry is improving, narrowing the gap with their wedded counterparts, according to new research that suggests the practice of encouraging marriage to promote health may be misguided.
Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.
A new preprint recently released on the bioRxiv* server describes the immunogenicity and protective potential of a novel adenovirus SARS-CoV-2 vaccine candidate against a form of the virus adapted to cause severe disease in mice. The findings show that this provides a useful mouse model for the study of new vaccines, in addition to demonstrating the protective efficacy of the current rhesus adenovirus vaccine candidate RhAd52.
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.
› Verified 7 days ago
Dr. Sujeev Vhan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3405 Mchenry Ave, T-0273, Modesto, CA 95350 Phone: 209-523-6210 | |
Cindie Masui, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1032 Oakdale Rd, Modesto, CA 95355 Phone: 209-577-6060 | |
Mrs. Truc Thanh Vo, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1101 Mchenry Ave, Modesto, CA 95350 Phone: 209-577-8695 | |
Grace Cho, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 Standiford Ave, Modesto, CA 95350 Phone: 209-522-1093 | |
Kenia Yulissa Medina Moreno, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1441 Florida Ave, Modesto, CA 95350 Phone: 209-576-3622 | |
Dr. Stephanie Tovar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 Coffee Rd, Modesto, CA 95355 Phone: 209-526-4500 | |
Ashley Avila, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Pelandale Ave, Modesto, CA 95356 Phone: 209-342-4902 |